Brain Transcriptional and Epigenetic Associations with Autism

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Ginsberg, Matthew R ^a   Rubin, Robert A ^b   Falcone, Tatiana ^c   Ting, Angela H ^c   Natowicz, Marvin R ^a,c  

^a CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^b WHITTIER COLLEGE   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN;

ARTICLE; AUTISM; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; DNA MICROARRAY; ENDOPHENOTYPE; EPIGENETICS; FEMALE; GENE EXPRESSION PROFILING; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN GENOME; HUMAN TISSUE; IMMUNE RESPONSE; INFLAMMATION; MALE; MYELINATION; NUCLEOTIDE SEQUENCE; OXIDATIVE PHOSPHORYLATION; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION;

ADOLESCENT; ADULT; AUTISTIC DISORDER; BRAIN; CHILD; CHILD, PRESCHOOL; DNA METHYLATION; EPIGENESIS, GENETIC; FRAGILE X SYNDROME; GENE DOSAGE; GENE EXPRESSION REGULATION; HUMANS; INFANT; INFLAMMATION; MALE; MIDDLE AGED; MITOCHONDRIA; MODELS, STATISTICAL; MYELIN SHEATH; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDATIVE PHOSPHORYLATION; PHENOTYPE; PROTEIN BIOSYNTHESIS; SEQUENCE ANALYSIS, DNA; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 84866309634     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044736     Document Type: Article

References (43)

1. Levy SE, Mandell DS, Schultz RT, (2009) Autism. Lancet 374: 1627-1638.
2. Betancur C, (2011) Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting. Brain Res 1380: 42-77.
3. Gillis RF, Fouleau GA, (2011) The ongoing dissection of the genetic architecture of autism spectrum disorder. Mol Autism 2: 12.
4. Devlin B, Scherer SW, (2012) Genetic architecture in autism spectrum disorder. Curr Opin Genet Develop 22: 1-9.
5. Sanders SJ, Murtha MT, Gupta AR, Murdoch JD, Raubeson MJ, et al. (2012) De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 485: 237-241.
6. Neale BM, Kou Y, Liu L, Ma'ayan A, Samocha KE, et al. (2012) Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 485: 242-246.
7. O'Roak BJ, Vives L, Girirajan S, Karakoc E, Krumm N, et al. (2012) Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 485: 246-250.
8. Chahrour MH, Yu TW, Lim ET, Ataman B, Coulter ME, et al. (2012) Whole exome sequencing and homozygosity analysis implicate depolarization-regulated neuronal genes in autism. PLoS Genet 8: e1002635.
9. Iossifov I, Ronemus M, Levy D, Wang Z, Hakker I, et al. (2012) De novo gene disruptions in children on the autistic spectrum. Neuron 74: 285-299.
10. Levitt P, Campbell DB, (2009) The genetic and neurobiologic compass points toward common signaling dysfunctions in autism spectrum disorders. J Clin Invest 119: 747-754.
11. Geschwind DH, (2011) Genetics of autism spectrum disorders. Trends Cogn Sci 15: 409-416.
12. Sakai Y, Shaw CA, Dawson BC, Dugas DG, Al-Muhtaseb Z, et al. (2011) Protein interactome reveals converging molecular pathways among autism disorders. Sci Transl Med 3: 1-10.
13. Voineagu I, Wang X, Johnston P, Lowe JK, Tian Y, et al. (2011) Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 474: 380-384.
14. Fatemi SH, Aldinger KA, Ashwood P, Bauman ML, Blaha GD, et al. (2012) Consensus paper: pathological role of the cerebellum in autism. Cerebellum 11: 777-807.
15. Ring HA, Baron-Cohen S, Wheelwright S, Williams SC, Brammer M, et al. (1999) Cerebral correlates of preserved cognitive skills in autism: a functional MRI study of embedded figures task performance. Brain 122: 1305-1315.
16. Hazlett EA, Buchsbaum MS, Hsieh P, Haznedar MM, Platholl J, et al. (2004) Regional glucose metabolism within cortical Brodmann areas in healthy individuals and autistic patients. Neuropsychobiology 49: 115-125.
17. Wintle RF, Lionel AC, Hu P, Ginsberg SD, Pinto D, et al. (2011) A genotype resource for postmortem brain samples from the Autism Tissue Program. Autism Res 4: 89-97.
18. Filipovic-Sadic S, Sah S, Chen L, Krosting J, Sekinger E, et al. (2010) A novel FMR1 PCR method for the routine detection of low abundance expanded alleles and full mutations in fragile X syndrome. Clin Chem 56: 399-408.
19. Voineagu I, (2012) Gene expression studies in autism: moving from the genome to the transcriptome and beyond. Neurobiol Dis 45: 69-75.
20. Glessner JT, Wang K, Cai G, Korvatska O, Kim CE, et al. (2009) Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature 459: 569-573.
21. Pinto D, Pagnamenta AT, Klei L, Anney R, Merico D, et al. (2010) Functional impact of global rare copy number variation in autism spectrum disorder. Nature 466: 368-372.
22. Sbacchi S, Acquadro F, Caio I, Romano V, (2010) Functional annotation of genes overlapping copy number variants in autistic patients: focus on axon pathfinding. Curr Genomics 11: 136-145.
23. Levy D, Ronemus M, Yamron B, Lee YH, Leotta A, et al. (2011) Rare de novo and transmitted copy-number variation in autistic spectrum disorders. Neuron 70: 886-897.
24. Gilman SR, Iossifov I, Levy D, Ronemus M, Wigler M, et al. (2011) Rare de novo variants associated with autism implicate a large functional network of genes involved in formation and function of synapses. Neuron 70: 898-907.
25. Giulivi C, Zhang YF, Omanska-Klusek A, Ross-Inta C, Wong S, et al. (2010) Mitochondrial dysfunction in autism. JAMA 304: 2389-2396.
26. Haas RH, (2010) Autism and mitochondrial disease. Dev Disabil Res Rev 16: 144-153.
27. Chauhan A, Gu F, Essa MM, Wegiel J, Kaur K, et al. (2011) Brain region-specific deficit in mitochondrial electron transport chain complexes in children with autism. J Neurochem 117: 209-220.
28. Garbett K, Ebert PJ, Mitchell A, Lintas C, Manzi B, et al. (2008) Immune transcriptome alterations in the temporal cortex of subjects with autism. Neurobiol Dis 30: 303-311.
29. Auerbach BD, Osterweil EK, Bear MF, (2011) Mutations causing syndromic autism define an axis of synaptic pathophysiology. Nature 480: 63-69.
30. Darnell JC, (2011) Defects in translational regulation contributing to human cognitive and behavioral disease. Curr Opin Genet Devel 21: 465-473.
31. Xu H, Lu A, Sharp FR, (2011) Regional genome transcriptional response of adult mouse brain to hypoxia. BMC Genomics 12: 499.
32. Xu LM, Li JR, Huang Y, Zhao M, Tang X, et al. (2012) AutismKB: an evidence-based knowledgebase of autism genetics. Nucl Acids Res 40: D1016-D1022.
33. Gregg JP, Lit L, Baron CA, Hertz-Picciotto I, Walker W, et al. (2008) Gene expression changes in children with autism. Genomics 91: 22-29.
34. Onore C, Careaga M, Ashwood P, (2012) The role of immune dysfunction in the pathophysiology of autism. Brain Behav Immun 26: 383-392.
35. Langfelder P, Horvath S, (2008) WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 9: 559.
36. Burnstock G, Fredholm BB, Verkhratsky A, (2011) Adenosine and ATP receptors in the brain. Curr Top Med Chem 11: 973-1011.
37. Anagnostou E, Taylor MJ, (2011) Review of neuroimaging in autism spectrum disorders: what have we learned and where we go from here. Mol Autism 2: 4.
38. Cheung C, Chua SE, Cheung V, Khong PL, Tai KS, et al. (2009) White matter fractional anisotrophy differences and correlates of diagnostic symptoms in autism. J Child Psych Psychiatr 50: 1102-1112.
39. Xin Y, Chanrion B, Liu MM, Galfaluy H, Costa R, et al. (2010) Genome-wide divergence of DNA methylation marks in cerebral and cerebellar cortices. PLoS ONE 5: e11357.
40. Nguyen A, Rauch TA, Pfeifer GP, Hu VW, (2010) Global methylation profiling of lymphoblastoid cell lines reveals epigenetic contributions to autism spectrum disorders and a novel autism candidate gene, RORA, whose protein product is reduced in autistic brain. FASEB J 24: 3036-3051.
41. Jiang YH, Sahoo T, Michaelis RC, Bercovich D, Bressler J, et al. (2004) A mixed epigenetic/genetic model for oligogenic inheritance of autism with a limited role for UBE3A. Am J Med Genet A 131: 1-10.
42. Nagarajan RP, Patzel KA, Martin M, Yarui DH, Swanberg SE, et al. (2008) MECP2 promoter methylation and X chromosome inactivation in autism. Autism Res 1: 169-178.
43. Gregory SG, Connelly JJ, Towers AJ, Johnson J, Biscocho D, et al. (2009) Genomic and epigenetic evidence for oxytocin receptor deficiency in autism. BMC Med 7: 62.